Latest News about BIIB
Recent news which mentions BIIB
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022
January 13, 2022
From Benzinga
Why Jim Cramer Prefers This Mining Stock Over Vale
January 13, 2022
From Benzinga
These S&P 500 stocks have cratered, but analysts think 12 can turn it around with rebounds of up to 70%
January 13, 2022
From MarketWatch
10 Biggest Price Target Changes For Thursday
January 13, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 12, 2022
From Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
January 12, 2022
From Benzinga
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
January 12, 2022
From Benzinga
Biogen’s stock tumbles after the U.S. proposes restricting access to its Alzheimer’s disease drug
January 12, 2022
From MarketWatch
Will This Stock's Pain Be Medicare's Gain?
January 12, 2022
From Motley Fool
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 12, 2022
From Benzinga
10 Biggest Price Target Changes For Wednesday
January 12, 2022
From Benzinga
From InvestorPlace
Watch out for stock headwinds and recessionary pressures, warns bond king Jeffrey Gundlach
January 12, 2022
From MarketWatch
From Benzinga
15 Stocks Moving in Wednesday's Pre-Market Session
January 12, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 11, 2022
From Benzinga
From Benzinga
Where Will Cassava Sciences Be in 1 Year?
January 07, 2022
From Motley Fool
Better Buy: Vertex Pharmaceuticals vs. Biogen
January 07, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.